Analysis of uterine corpus endometrial carcinoma and esophageal carcinoma, two cancer types with the most prominent SHANK2 overexpression, showed that expression of SHANK2 positively correlates with CTGF and CYR61 (Fig. 3G). This evidence concerns the gene SHANK2 and uterine corpus endometrial carcinoma.